Merck's Branded Generics Will Play A Supplementary, Country-specific Role

MUMBAI - Merck is putting into play a branded generics business strategy that involves extracting value out of a large set of its off-patented drugs through an aggressive push into developing markets, where the "lifecycle value of its brands" is significantly higher as compared to developed markets

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip